Drug Distributors Ride Weight-Loss Hype But Valuations Stay Low
Lesser-known pharmaceutical distributors are quietly cashing in on the hype around Novo Nordisk A/S and Eli Lilly & Co.’s weight-loss drugs, without their valuations being bid up to the same lofty heights. #press
